What is OMED Health Plans?
OMED Health Plans combine our Breath Analyzer and App with doctor-led diagnosis, treatment, and gut health support. By measuring hydrogen and methane, we detect SIBO and IMO and monitor your response to treatment over time.
Problem
Users manage digestive health issues (e.g., SIBO, IMO) through repeated doctor visits and invasive tests, which are time-consuming, costly, and lack real-time monitoring.
Solution
A breath analyzer and app platform enabling users to measure hydrogen/methane levels for non-invasive detection and monitoring of digestive disorders, supported by doctor-led diagnosis and treatment plans.
Customers
Individuals with chronic digestive symptoms (e.g., bloating, IBS) and healthcare providers seeking objective data for diagnosis and treatment tracking.
Unique Features
Combines breath biomarker analysis with clinician-guided care plans, enabling continuous monitoring and personalized interventions.
User Comments
Non-invasive alternative to traditional tests
Easy to track progress over time
Improves communication with doctors
Reduces diagnostic uncertainty
Supports long-term gut health management
Traction
Launched in 2023, partnered with 10+ clinics, raised $2M pre-seed funding, early pilots show 85% user adherence rate.
Market Size
The global gut health diagnostics market is projected to reach $7.5 billion by 2027, growing at 8.3% CAGR (Grand View Research 2023).
